申请人:THERAVANCE BIOPHARMA R&D IP, LLC
公开号:US20210079017A1
公开(公告)日:2021-03-18
In one aspect, the invention relates to compounds having the formula:
where R
1
-R
6
, a, b, and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.